Nov 8, 2018 08:00AM Aeglea BioTherapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

Nov 8, 2018 08:00AM Aeglea BioTherapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

Jun 14, 2018 05:25AM UPDATE: BMO Capital Starts Aeglea Biotherapeutics (AGLE) at Outperform

Apr 19, 2018 05:40AM Aeglea BioTherapeutics (AGLE) Prices 4.5M Share Common Offering at $8/Sh

Apr 18, 2018 10:50PM Aeglea BioTherapeutics Prices Public Offering of Common Stock

Apr 18, 2018 10:50PM Aeglea BioTherapeutics Prices Public Offering of Common Stock

Apr 17, 2018 04:02PM Aeglea BioTherapeutics (AGLE) Announces 4.5M Share Common Offering

Apr 17, 2018 04:01PM Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock

Apr 17, 2018 04:01PM Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock

Mar 14, 2018 07:42AM Aeglea Biotherapeutics (AGLE) PT Lowered to $18 at BMO Capital

Dec 7, 2017 04:05PM Aeglea BioTherapeutics to Present at BMO Capital Markets Prescriptions for Success Healthcare Conference

Dec 7, 2017 04:05PM Aeglea BioTherapeutics to Present at BMO Capital Markets Prescriptions for Success Healthcare Conference

Nov 7, 2017 04:05PM Aeglea BioTherapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results

Dec 7, 2016 08:00AM Aeglea BioTherapeutics to Present at BMO Capital Markets Prescription for Success Healthcare Conference

May 2, 2016 06:31AM BMO Capital Starts Aeglea Biotherapeutics (AGLE) at Outperform

Apr 12, 2016 04:00PM Aeglea BioTherapeutics Announces Closing of Initial Public Offering and Partial Exercise of the Underwriters’ Option

Apr 7, 2016 10:55AM Aeglea BioTherapeutics (AGLE) IPO Opens Flat

Apr 7, 2016 12:00AM Aeglea BioTherapeutics Announces Pricing of Initial Public Offering